Zhang et al. found that MELK phosphorylated an inhibitory subunit of mTORC1 PRAS40 and then activated the mTORC1, thus promoting the malignant phenotype of ccRCC cells [35]. The gene discussed is MELK; the disease is nonpapillary renal cell carcinoma.